Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy

Maropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohyster...

Full description

Saved in:
Bibliographic Details
Main Authors: Janaina M. X. Corrêa, Priscila C. L. R. Soares, Raquel V. Niella, Brenda A. Costa, Maxuel S. Ferreira, Alex C. Silva Junior, Aline S. Sena, Kátia M. O. R. Sampaio, Elisângela B. Silva, Fabiana L. Silva, Mário S. L. Lavor
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Veterinary Medicine International
Online Access:http://dx.doi.org/10.1155/2019/9352528
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564707094953984
author Janaina M. X. Corrêa
Priscila C. L. R. Soares
Raquel V. Niella
Brenda A. Costa
Maxuel S. Ferreira
Alex C. Silva Junior
Aline S. Sena
Kátia M. O. R. Sampaio
Elisângela B. Silva
Fabiana L. Silva
Mário S. L. Lavor
author_facet Janaina M. X. Corrêa
Priscila C. L. R. Soares
Raquel V. Niella
Brenda A. Costa
Maxuel S. Ferreira
Alex C. Silva Junior
Aline S. Sena
Kátia M. O. R. Sampaio
Elisângela B. Silva
Fabiana L. Silva
Mário S. L. Lavor
author_sort Janaina M. X. Corrêa
collection DOAJ
description Maropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohysterectomy. Thirty cats were randomly assigned to one of three groups (10 cats each group): the control group (CG) received a continuous infusion of 10 ml/kg/h Ringer’s lactate; GM30 and GM100 first received an intravenous (IV) bolus of 1 mg/kg maropitant; GM30 then received continuous infusion of 30 μg/kg/h maropitant; and GM100 then received continuous infusion of 100 μg/kg/h maropitant. The maropitant was diluted into Ringer’s lactate and the GM30 and GM100 also received fluids intraoperatively. In all groups, premedication included intramuscular injections of morphine and acepromazine, followed by induction with propofol and maintenance with isoflurane. Temperature, heart rate (HR), Doppler blood pressure (DBP), respiratory rate, oxygen saturation, and measuring the end-tidal carbon dioxide and isoflurane were monitored. Postoperative pain was evaluated using a visual analog scale and the UNESP-Botucatu multidimensional composite pain scale in cats; morphine was used for analgesic rescue. During the surgical procedure, cats in GM100 demonstrated lower HR and DBP than those in CG. With regard to the evaluation of postoperative pain, GM100 required the least frequent morphine rescue and less rescue analgesia compared with CG. In conclusion, cats in GM100 maintained lower DBP and HR and required lower analgesic rescue during the postoperative period. The results suggested that animals receiving maropitant bolus (1 mg/kg) plus (100 μg/kg/h) experienced greater postoperative comfort, reflected by the lesser need for analgesic rescue. The use of maropitant in surgical procedures in cats contributes to postoperative comfort.
format Article
id doaj-art-ba166c8e7a0440e39aa191c8eecfd974
institution Kabale University
issn 2090-8113
2042-0048
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Veterinary Medicine International
spelling doaj-art-ba166c8e7a0440e39aa191c8eecfd9742025-02-03T01:10:26ZengWileyVeterinary Medicine International2090-81132042-00482019-01-01201910.1155/2019/93525289352528Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing OvariohysterectomyJanaina M. X. Corrêa0Priscila C. L. R. Soares1Raquel V. Niella2Brenda A. Costa3Maxuel S. Ferreira4Alex C. Silva Junior5Aline S. Sena6Kátia M. O. R. Sampaio7Elisângela B. Silva8Fabiana L. Silva9Mário S. L. Lavor10Postgraduate Program in Animal Science, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilPostgraduate Program in Animal Science, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilPostgraduate Program in Animal Science, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilPostgraduate Program in Animal Science, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilDepartment of Agricultural and Environmental Sciences, State University of Santa Cruz (UESC), Ilhéus, Bahia, BrazilMaropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohysterectomy. Thirty cats were randomly assigned to one of three groups (10 cats each group): the control group (CG) received a continuous infusion of 10 ml/kg/h Ringer’s lactate; GM30 and GM100 first received an intravenous (IV) bolus of 1 mg/kg maropitant; GM30 then received continuous infusion of 30 μg/kg/h maropitant; and GM100 then received continuous infusion of 100 μg/kg/h maropitant. The maropitant was diluted into Ringer’s lactate and the GM30 and GM100 also received fluids intraoperatively. In all groups, premedication included intramuscular injections of morphine and acepromazine, followed by induction with propofol and maintenance with isoflurane. Temperature, heart rate (HR), Doppler blood pressure (DBP), respiratory rate, oxygen saturation, and measuring the end-tidal carbon dioxide and isoflurane were monitored. Postoperative pain was evaluated using a visual analog scale and the UNESP-Botucatu multidimensional composite pain scale in cats; morphine was used for analgesic rescue. During the surgical procedure, cats in GM100 demonstrated lower HR and DBP than those in CG. With regard to the evaluation of postoperative pain, GM100 required the least frequent morphine rescue and less rescue analgesia compared with CG. In conclusion, cats in GM100 maintained lower DBP and HR and required lower analgesic rescue during the postoperative period. The results suggested that animals receiving maropitant bolus (1 mg/kg) plus (100 μg/kg/h) experienced greater postoperative comfort, reflected by the lesser need for analgesic rescue. The use of maropitant in surgical procedures in cats contributes to postoperative comfort.http://dx.doi.org/10.1155/2019/9352528
spellingShingle Janaina M. X. Corrêa
Priscila C. L. R. Soares
Raquel V. Niella
Brenda A. Costa
Maxuel S. Ferreira
Alex C. Silva Junior
Aline S. Sena
Kátia M. O. R. Sampaio
Elisângela B. Silva
Fabiana L. Silva
Mário S. L. Lavor
Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
Veterinary Medicine International
title Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_full Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_fullStr Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_full_unstemmed Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_short Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_sort evaluation of the antinociceptive effect of maropitant a neurokinin 1 receptor antagonist in cats undergoing ovariohysterectomy
url http://dx.doi.org/10.1155/2019/9352528
work_keys_str_mv AT janainamxcorrea evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT priscilaclrsoares evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT raquelvniella evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT brendaacosta evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT maxuelsferreira evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT alexcsilvajunior evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT alinessena evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT katiamorsampaio evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT elisangelabsilva evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT fabianalsilva evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT mariosllavor evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy